AX
AXXA.US RCABS Inc
- Market cap
- USD 1.61M
- P/E
- -
- P/B
- 0.03x
- ROE
- 1.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is AXXA.US undervalued?
Graham numberThe Graham number of RCABS Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RCABS Inc fundamental analysis
No fundamental analysis for RCABS Inc yet.
RCABS Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RCABS Inc
Exxe Group Inc. focuses on real estate, sustainable technology, media, agribusiness, and financial services businesses. The company buys, develops, and manages real estate properties, including condominiums, hotels, vacation homes, residential complexes, senior living communities, offices, and self-storage facilities. It also provides financing and execution services; advises issuers and investors through financing, acquisition, and exit strategies; and delivers services to …
Full company profileRCABS Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RCABS Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 78.8K | 2.10M | 15.3M | 33.9M | 49.8M | 53.1M | 63.2M | 62.8M | 70.9M | 66.7M |
| Gross Profit | -133K | 64.2K | 1.78M | 6.46M | 11.0M | 23.8M | 17.7M | 30.2M | 29.8M | 32.3M | 18.1M |
| Operating Income | -187K | -146K | 914K | 4.38M | 10.6M | 23.4M | 16.5M | 22.2M | 21.3M | 20.4M | 1.26M |
| EBITDA | -54.6K | -146K | 915K | 4.56M | 7.04M | 11.1M | 16.8M | -6.75M | 21.5M | 20.4M | 9.26M |
| Net Income | -232K | -174K | 1.69M | 3.56M | 6.64M | 10.8M | 11.6M | -5.41M | 7.98M | 497K | 1.26M |
| EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 2.62K | 29.9K | 65.3M | 193M | 222M | 253M | 258M | 173M | 154M | 100M | 98.0M |
| Total Liabilities | 1.07M | 558K | 27.6M | 76.5M | 83.6M | 80.2M | 62.6M | 31.2M | 22.1M | 19.3M | 16.7M |
| Shareholders' Equity | -1.07M | -528K | 2.22M | 30.3M | 41.7M | 61.6M | 80.1M | 85.0M | 94.5M | 81.1M | 81.3M |
| Cash & Short-term Investments | 2.62K | 3.43K | 304K | 398K | 238K | 259K | 644K | 468K | 855K | 836K | 986K |
| Total Debt | 460K | 490K | 27.4M | 70.1M | 74.9M | 65.4M | 51.9M | 29.5M | 21.5M | 18.4M | 16.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -57.1K | -5.67K | -5.07M | 227K | 2.49M | 13.4M | 12.2M | 3.01M | 10.0M | -1.91M | - |
| Capital Expenditure | 19.2M | 19.2M | 24.7M | 9.84M | 8.05M | 4.37M | 4.29M | 1.00M | 5.00M | 1.91M | - |
| Free Cash Flow | -57.1K | -5.67K | -29.8M | -9.61M | -5.55M | 9.00M | 7.91M | 2.01M | 5.03M | - | - |
| Ratios | |||||||||||
| ROE | - | - | 76.1% | 11.7% | 15.9% | 17.6% | 14.5% | -6.4% | 8.4% | 0.6% | 1.5% |
| ROA | -8,849.0% | -582.2% | 2.6% | 1.8% | 3.0% | 4.3% | 4.5% | -3.1% | 5.2% | 0.5% | 1.3% |
| Net Profit Margin | - | -221.1% | 80.2% | 23.2% | 19.6% | 21.8% | 21.9% | -8.6% | 12.7% | 0.7% | 1.9% |
| Debt to Equity | - | - | 12.36x | 2.32x | 1.80x | 1.06x | 0.65x | 0.35x | 0.23x | 0.23x | 0.20x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
RCABS Inc dividends
RCABS Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:5000 on Oct 14, 2016.
Who owns RCABS Inc
Ownership data of RCABS Inc is not available yet.
RCABS Inc company profile
- Company name
- RCABS Inc
- Ticker
- AXXA.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Fiscal year end
- March
- Address
- 1345 Avenue of The Americas, New York, NY, United States, 10105
- Phone
- 855 285 2285
- Website
- exxegroup.com
About RCABS Inc
Exxe Group Inc. focuses on real estate, sustainable technology, media, agribusiness, and financial services businesses. The company buys, develops, and manages real estate properties, including condominiums, hotels, vacation homes, residential complexes, senior living communities, offices, and self-storage facilities. It also provides financing and execution services; advises issuers and investors through financing, acquisition, and exit strategies; and delivers services to investors through media and tech. It serves connectivity, and healthcare sectors. The company was formerly known as Telecorp, Inc. Exxe Group Inc. was incorporated in 2009 and is based in New York, New York.
RCABS Inc management
6- Dr. Eduard Nazmiev Ph.D.CFO, CEO & Chairman of the Board
- Ms. Anna IvanchenkoChief Marketing Officer
- Ms. Darla GullonsMD of Special Project & Director
- Mr. Boris MatsokhinManaging Director of Strategy
- Mr. Peter SalladeMD of Digital Media & Director
- Ms. Joanna Filipowska Ph.D.Head of Biotech & Medical Sciences and Director